Minerva Neurosciences (NERV) Other Non-Current Liabilities (2013 - 2026)

Minerva Neurosciences has reported Other Non-Current Liabilities for 11 years, with the latest figure at $60.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities changed 0.0% year-over-year to $60.0 million; the trailing twelve-month figure through Mar 2026 stood at $60.0 million (changed 0.0% YoY), and the FY2025 full-year result was $60.0 million, changed N/A from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $60.0 million, roughly flat from $60.0 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $86.6 million in Q2 2024, with the low at $60.0 million in Q3 2024.
• Historically, Other Non-Current Liabilities has averaged $70.6 million across 5 years, with a median of $70.9 million in 2022.
• Annual changes were most pronounced in 2024 — Other Non-Current Liabilities climbed 11.37% — and 2025, when it tumbled 30.7%.
• Minerva Neurosciences' Other Non-Current Liabilities stood at $73.7 million in 2022, then rose by 11.23% to $82.0 million in 2023, then fell by 26.84% to $60.0 million in 2024, then changed by 0.0% to $60.0 million in 2025, then changed by 0.0% to $60.0 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $60.0 million (Q1 2026), $60.0 million (Q4 2025), and $60.0 million (Q3 2025), per Business Quant data.